Research ArticlesAcceleration of Peritoneal Dialysis With Minimal N-myristyl-β-aminopropionate
-
Add time:08/31/2019 Source:sciencedirect.com
A single short-term exposure of the peritoneal membrane to N-myristyl-β-aminopropionic acid solution (0.25%) gave an accelerating effect on the peritoneal clearance of salicylate, barbiturate, and diphenylhydantoin, which lasted throughout several subsequent exchanges with standard dialysis fluid. A brief kinetic study on N-myristyl-β-aminopropionate was done, and its intraperitoneal absorption and urinary and peritoneal clearances are reported. The LD50 of this wetting agent in mice and its hemolytic threshold were also estimated.
We also recommend Trading Suppliers and Manufacturers of MYRISTYL SALICYLATE (cas 19666-17-2). Pls Click Website Link as below: cas 19666-17-2 suppliers
Prev:Preparation and characterization of an IPN type chelating resin containing amino and carboxyl groups for removal of Cu(II) from aqueous solutions
Next:Research ArticlesAccelerated Peritoneal Dialysis of Barbiturates, Diphenylhydantoin, and Salicylate) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticleSpecific and saturable binding of pp60v-src to plasma membranes: Evidence for a myristyl-src receptor09/03/2019
- Research ArticlesAccelerated Removal of Salicylate by Additives in Peritoneal Dialysis Fluid09/02/2019
- Research ArticlesAccelerated Peritoneal Dialysis of Barbiturates, Diphenylhydantoin, and Salicylate09/01/2019
-
Health and Chemical more >


